Argenx reports first quarter 2021 financial results and provides business update

Japanese marketing authorization application (j-maa) for efgartigimod accepted for review by japan's pharmaceuticals and medical device agency (pmda) for generalized myasthenia gravis (gmg)

ARGX Ratings Summary

ARGX Quant Ranking